These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 19734480)

  • 41. Prognostic significance of PU.1 in follicular lymphoma.
    Torlakovic EE; Bilalovic N; Golouh R; Zidar A; Angel S
    J Pathol; 2006 Jul; 209(3):352-9. PubMed ID: 16639693
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bcl-6 predicts improved prognosis in primary central nervous system lymphoma.
    Levy O; Deangelis LM; Filippa DA; Panageas KS; Abrey LE
    Cancer; 2008 Jan; 112(1):151-6. PubMed ID: 17999414
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
    Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
    Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. B-cell posttransplant lymphoproliferative disorders in heart and/or lungs recipients: clinical and molecular-histogenetic study of 17 cases from a single institution.
    Lucioni M; Capello D; Riboni R; Ippoliti G; Campana C; Bandiera L; Arcaini L; Rossi D; Cerri M; Dionigi P; Lazzarino M; Magrini U; Viganò M; Gaidano G; Paulli M
    Transplantation; 2006 Oct; 82(8):1013-23. PubMed ID: 17060848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary diffuse large B-cell lymphoma of bone displays preferential rearrangements of the c-MYC or BCL2 gene.
    Lima FP; Bousquet M; Gomez-Brouchet A; de Paiva GR; Amstalden EM; Soares FA; Dastugue N; Vassallo J; Brousset P
    Am J Clin Pathol; 2008 May; 129(5):723-6. PubMed ID: 18426731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New time-dependent approach to analyse the prognostic significance of immunohistochemical biomarkers in colon cancer and diffuse large B-cell lymphoma.
    Adams H; Tzankov A; Lugli A; Zlobec I
    J Clin Pathol; 2009 Nov; 62(11):986-97. PubMed ID: 18977805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases.
    Tzankov A; Pehrs AC; Zimpfer A; Ascani S; Lugli A; Pileri S; Dirnhofer S
    J Clin Pathol; 2003 Oct; 56(10):747-52. PubMed ID: 14514777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of CD68+ tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis.
    Hasselblom S; Hansson U; Sigurdardottir M; Nilsson-Ehle H; Ridell B; Andersson PO
    Pathol Int; 2008 Aug; 58(8):529-32. PubMed ID: 18705775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas.
    Hallermann C; Niermann C; Fischer RJ; Schulze HJ
    J Am Acad Dermatol; 2007 Apr; 56(4):588-97. PubMed ID: 17289214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oncologic outcomes of primary lymphoma of bone in adults.
    Lewis VO; Primus G; Anastasi J; Doherty D; Montag AG; Peabody TD; Simon MA
    Clin Orthop Relat Res; 2003 Oct; (415):90-7. PubMed ID: 14612634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extranodal diffuse large B cell lymphoma of cutaneous follicle centre lymphoma type: a study of 24 patients with non-cutaneous primary limited stage extranodal diffuse large B cell lymphoma in support of a new concept.
    Aigner F; Korol D; Schmitt AM; Kurrer MO
    Histopathology; 2012 Apr; 60(5):774-84. PubMed ID: 22304695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary lymphoma of the liver -- morphological and clinical analysis of 6 cases. Success of aggressive treatment.
    Ziarkiewicz-Wroblewska B; Gornicka B; Suleiman W; Wroblewski T; Morton M; Wilczynski GM; Heleniak H; Skwarek A; Koperski L; Dudek K; Krawczyk M; Jedrzejczak WW; Dwilewicz-Trojaczek J; Wasiutynski A
    Neoplasma; 2005; 52(3):267-72. PubMed ID: 15875091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcome.
    Ponzoni M; Ferreri AJ; Pruneri G; Pozzi B; Dell'Oro S; Pigni A; Pinotti G; Villa E; Freschi M; Viale G; Capella C
    Int J Cancer; 2003 Aug; 106(2):288-91. PubMed ID: 12800208
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Testicular lymphoma--a retrospective, population-based, clinical and immunohistochemical study.
    Hasselblom S; Ridell B; Wedel H; Norrby K; Sender Baum M; Ekman T
    Acta Oncol; 2004; 43(8):758-65. PubMed ID: 15764222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
    Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
    J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cutaneous B cell processes with nodular pattern].
    Chirife AM; Bilbao ER; Giménez L; Marino L
    Medicina (B Aires); 2006; 66(4):307-12. PubMed ID: 16977965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Analysis of prognostic factors in 74 cases of diffuse large B-cell lymphoma].
    Wang J; Ke XY; Zhao LZ; Li M; Jing HM; Wang JJ; Zhao W; Gao ZF
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):667-70. PubMed ID: 18399171
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma.
    Colomo L; López-Guillermo A; Perales M; Rives S; Martínez A; Bosch F; Colomer D; Falini B; Montserrat E; Campo E
    Blood; 2003 Jan; 101(1):78-84. PubMed ID: 12393466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of germinal center B-cell lymphoma in archival specimens: critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the tonsil.
    Ree HJ; Ohsima K; Aozasa K; Takeuchi K; Kim CW; Yang WI; Huh JY; Lee SS; Ko YH; Kwon MS; Cho EY; Choi YL; Rhee JC; Kikuchi M; Mori S
    Hum Pathol; 2003 Jun; 34(6):610-6. PubMed ID: 12827616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.